Status | Study |
RECRUITING |
Study Name: Verification of the Efficacy/Safety of the Intratympanic Drug Delivery for Hearing Loss Condition: Hearing Loss, Sudden Date: 2021-02-17 Interventions: Dexamethasone 5mg/ml |
Terminated |
Study Name: Study of the Effects of Anakinra in Corticosteroid-resistant Subjects With Sudden Sensorineural Hearing Loss Condition: Hearing Loss, Sudden Date: 2015-02-23 Interventions: Drug: anakinra 100mg of anakinra adminstered by a subcutaneous injection for a minimum of 28 days, retre |
Suspended |
Study Name: Sudden Hearing Loss Multi-center Clinical Trial Condition: Full-frequency Sudden Hearing Loss Date: 2013-12-29 Interventions: Drug: Dexamethasone Phosphate |
Recruiting |
Study Name: Efficacy, Safety, and Tolerability of Ancrod in Patients With Sudden Hearing Loss Condition: Hearing Loss Deafness Hearing Loss, Sensorineural Date: 2012-06-12 Interventions: Drug: Ancrod Day 1: Intravenou |
Completed |
Study Name: The Effect of Antiviral Therapy With Pegylated Interferon-alpha on Auditory Disability Condition: Hearing Loss Sudden Deafness Date: 2010-12-01 |
Completed |
Study Name: Fludrocortisone for Sudden Hearing Loss Condition: Hearing Loss, Sensorineural Date: 2010-08-19 Interventions: Drug: Fludrocortisone Fludrocortisone 0.2 mg by mouth daily for 30 days |
Suspended |
Study Name: Caroverin and Inner Ear Diseases Condition: Tinnitus Date: 2010-08-02 Interventions: Drug: Caroverin treatment with eardrops 2 times for 48 hours |
Completed |
Study Name: Efficacy of AM-111 in Patients With Acute Sensorineural Hearing Loss Condition: Hearing Loss Date: 2008-12-03 Interventions: Drug: AM-111 single intratympa |
Terminated |
Study Name: Bed Rest for Idiopathic Sudden Sensorineural Hearing Loss Condition: Sudden Loss of Hearing Date: 2006-12-24 Interventions: Procedure: bed rest Drug: prednisone - ora |
Completed |
Study Name: Safety and Efficacy of Intratympanic Application of Dexamethasone Via Catheter in Patients With Sudden Hearing Loss Condition: Sudden Deafness Date: 2006-06-09 Interventions: Drug: Dexamethasone-dihydrogenphosphate (4mg/ml) |